PATENT CLAIM ANALYSIS

Application Number: 15939828
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-10
Patent Classification: ["514", "294000"]

Abstract:
The invention relates to pharmaceutical compositions containing both (+)-α-dihydrotetrabenazine and (−)-α-dihydrotetrabenazine and their therapeutic uses, for example in the treatment of movement disorders, such as Tourette's syndrome.

Claim (Index 13):
A method according to  claim 5 , wherein the combination of (+)-\u03b1-dihydrotetrabenazine and (\u2212)-\u03b1-dihydrotetrabenazine is a scalemic mixture.

Metadata:
- Claim Count in Document: 21.0
- Percentile: 90.0
- Lexical Diversity: 1.15625
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15939837', '15939826', '12555695', '15116786', '15044655']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8107169219163904
- 35 USC 102 Novelty (BERT): 0.6262076343164263
- Combined Prediction Score: 0.792265993156394
- Mean Citation Score: 426.957636
- Max Citation Score: 652.2701
- Similarity Product: 510.25266230849616

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test